Displaying 441 - 460 of 709
Ginger Jin Named Director of FTC’s Bureau of Economics; Alison Oldale Named BE Deputy Director for Antitrust
Date
Federal Trade Commission Chairwoman Edith Ramirez has appointed Professor Ginger Zhe Jin as Director of its Bureau of Economics, succeeding Francine Lafontaine, who is returning to the University of...
FTC Issues Agency Financial Report for Fiscal Year 2015
Date
The Federal Trade Commission’s Fiscal Year 2015 Agency Financial Report provides an overview of fiscal and key performance results that show how the agency has managed its resources. The report...
FTC and Veterans Administration Sign Agreement Furthering Efforts To Protect Service Members Who Use Military Education Benefits
Date
The Federal Trade Commission and the Veterans Administration signed a Memorandum of Agreement to further their ongoing efforts to stop fraudulent and deceptive practices targeted at U.S. service...
FTC Staff Provides Comments to FDA on Naming Proposal for Biologic Products
Date
The staff of the Federal Trade Commission has submitted a comment to the U.S. Food and Drug Administration in response to the FDA’s request for comment on its draft guidance addressing nonproprietary...
Public Statement
Transatlantic Privacy After Schrems: Time for An Honest Conversation
Date
File
Text of the Speech
(129.21 KB)
FTC Chairwoman Ramirez Testifies Before Congress on Legislation That Would Alter the Agency’s Role in Adjudicating Merger Cases
Date
In testimony presented to a subcommittee of the Senate Judiciary Committee the Federal Trade Commission described its work to promote competition, and its concerns about proposed federal legislation...
Public Statement
Keynote Address Before Bitkom Privacy Conference
Date
File
Text of the Speech
(43.37 KB)
Public Statement
Tech for Good: Data for Social Empowerment
Date
File
Tech for Good: Data for Social Empowerment
(34.04 KB)
FTC Staff Comment: FDA Should Reevaluate Its Current Regulatory Framework for Homeopathic Products
Date
The staff of the Federal Trade Commission has recommended that the U.S. Food and Drug Administration reconsider the framework it uses to regulate homeopathic medications because it may appear to...
FTC Staff Comment Before the Food and Drug Administration Regarding the Current Use of Human Drug and Biological Products Labeled As Homeopathic, and the FDA's Regulatory Framework For Such Products
Date
Matter Number
P114505
Docket Number
80 Fed. Reg. 16327 (Mar. 27, 2015)
FTC staff has recommended that the U.S. Food and Drug Administration (FDA) reconsider the framework it uses to regulate homeopathic medications because it may appear to conflict with the FTC’s...
File
Exhibit A
(1.61 MB)
File
Exhibit B-Part 1
(2.51 MB)
File
Exhibit B-Part 2
(3.34 MB)
File
Exhibit C
(5.08 MB)
Displaying 441 - 460 of 709